Company · CIK 0001533040 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Phio Pharmaceuticals Corp. · PHIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 PForm 4 → | Sep 25, 4:01 pm EDT | Patricia A BradfordDirector | 6,500 | $1.01 | $6,583 | 64,151 | +11.3% | |
| Sep 22, 2026 PForm 4 → | Sep 23, 4:01 pm EDT | Robert J BittermanChairman, Pres. & CEO, Director | 2,000 | $1.03 | $2,058 | 364,871 | +0.55% | |
| Sep 15, 2026 PForm 4 → | Sep 16, 4:01 pm EDT | Patricia A BradfordDirector | 12,000 | $1.03 | $12,360 | 57,651 | +26.3% | |
| Sep 11, 2026 FForm 4 → | Sep 15, 4:00 pm EDT | Lisa Cabott CarsonChief Financial Officer | 12,888 | $1.03 | $13,275 | 81,112 | — | |
| Sep 11, 2026 FForm 4 → | Sep 15, 4:00 pm EDT | Robert J BittermanChairman, Pres. & CEO, Director | 68,550 | $1.03 | $70,607 | 362,871 | — | |
| Aug 19, 2026 PForm 4 → | Aug 20, 8:30 am EDT | Ronald Todd PlottDirector | 15,000 | $1.14 | $17,100 | 15,000 | — | |
| Aug 18, 2026 PForm 4 → | Aug 19, 4:01 pm EDT | Robert J BittermanChairman, Pres. & CEO, Director | 10,000 | $1.06 | $10,600 | 431,421 | +2.37% | |
| Jun 26, 2026 PForm 4 → | Jun 29, 4:02 pm EDT | Robert J BittermanChairman, Pres. & CEO, Director | 10,000 | $0.99 | $9,900 | 421,421 | +2.43% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.